| Literature DB >> 19519528 |
Thomas Vargues1, Gareth J Morrison, Emily S Seo, David J Clarke, Helen L Fielder, Julien Bennani, Uday Pathania, Fiona Kilanowski, Julia R Dorin, John R W Govan, C Logan Mackay, Dusan Uhrín, Dominic J Campopiano.
Abstract
Human beta-defensin 2 (HBD2) has been shown to interact with pathogenic bacteria and components of the mammalian innate and adaptive immune response. We describe a quick and reliable method for the production of HBD2 in Escherichia coli. HBD2 was expressed as an insoluble fusion, chemically cleaved and oxidised to give a single, folded HBD2 beta-isoform. The purified peptide was analysed by high resolution mass spectrometry, displayed a well-dispersed (1)H NMR spectrum, was a chemoattractant to HEK293 cells expressing CCR6 and acted as an antimicrobial agent against E. coli, P. aeruginosa, C. albicans and S. aureus.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19519528 DOI: 10.2174/092986609788490122
Source DB: PubMed Journal: Protein Pept Lett ISSN: 0929-8665 Impact factor: 1.890